[#item_full_content]
TORONTO–(BUSINESS WIRE)– #BrainHealth–VoxNeuro receives FDA 510(k) clearance for cfNI software and engages Stillwater Capital to explore strategic partnerships.
[#item_full_content]TORONTO–(BUSINESS WIRE)– #BrainHealth–VoxNeuro receives FDA 510(k) clearance for cfNI software and engages Stillwater Capital to explore strategic partnerships.